Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleRadionuclide Therapy

The Effect of 131I Therapy on the Eradication of Helicobacter pylori in Patients with Thyroid Disorders: A Preliminary Study

Farhad Pourfarzi, Hossein Pakrouy, Ali Mohammadian Erdi and Elnaz Faghfuri
Journal of Nuclear Medicine Technology June 2024, 52 (2) 144-147; DOI: https://doi.org/10.2967/jnmt.123.266508
Farhad Pourfarzi
1Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossein Pakrouy
2Ardabil Nuclear Medicine Center, Ardabil University of Medical Sciences, Ardabil, Iran; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Mohammadian Erdi
3Department of Anesthesiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elnaz Faghfuri
1Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 52 no. 2 144-147
DOI 
https://doi.org/10.2967/jnmt.123.266508
PubMed 
38839127

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication August 10, 2023
  • Revision received November 6, 2023
  • Published online June 5, 2024.

Article Versions

  • previous version (January 9, 2024 - 08:25).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Farhad Pourfarzi1,
  2. Hossein Pakrouy2,
  3. Ali Mohammadian Erdi3 and
  4. Elnaz Faghfuri1
  1. 1Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran;
  2. 2Ardabil Nuclear Medicine Center, Ardabil University of Medical Sciences, Ardabil, Iran; and
  3. 3Department of Anesthesiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
  1. For correspondence or reprints, contact Elnaz Faghfuri (elnaz.faghfuri{at}gmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2024 to April 2025

AbstractFullPdf
Jan 2024478124
Feb 2024484515
Mar 2024442612
Apr 2024283615
May 20245484
Jun 2024527107
Jul 2024420107
Aug 2024439117
Sep 202422527
Oct 202417300
Nov 202415811
Dec 20249112
Jan 2025129310
Feb 2025642111
Mar 2025582412
Apr 2025711725
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 52 (2)
Journal of Nuclear Medicine Technology
Vol. 52, Issue 2
June 1, 2024
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of 131I Therapy on the Eradication of Helicobacter pylori in Patients with Thyroid Disorders: A Preliminary Study
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
The Effect of 131I Therapy on the Eradication of Helicobacter pylori in Patients with Thyroid Disorders: A Preliminary Study
Farhad Pourfarzi, Hossein Pakrouy, Ali Mohammadian Erdi, Elnaz Faghfuri
Journal of Nuclear Medicine Technology Jun 2024, 52 (2) 144-147; DOI: 10.2967/jnmt.123.266508

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Effect of 131I Therapy on the Eradication of Helicobacter pylori in Patients with Thyroid Disorders: A Preliminary Study
Farhad Pourfarzi, Hossein Pakrouy, Ali Mohammadian Erdi, Elnaz Faghfuri
Journal of Nuclear Medicine Technology Jun 2024, 52 (2) 144-147; DOI: 10.2967/jnmt.123.266508
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen
  • Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States
  • First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Show more Radionuclide Therapy

Similar Articles

Keywords

  • Helicobacter pylori
  • 131I
  • differentiated thyroid carcinoma
  • hyperthyroidism
SNMMI

© 2025 SNMMI

Powered by HighWire